* iSpecimen Inc ISPC.OQ ISPC.O is expected to report
results
* The Lexington Massachusetts-based company is expected to
report
revenue of $3.25 million, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for iSpecimen Inc is
for a
loss of 22 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the software peer
group
is also "Buy".
* Wall Street's median 12-month price target for iSpecimen
Inc is
$16, about 69.4% above its last closing price of $4.90.
This summary was machine generated February 15 at 19:31 GMT.
All figures in US dollars unless otherwise stated